Samsung Electronics Co. accounted for 28.4 percent of smartphone sales in Russia in the third quarter to edge Chinese rival Huawei Technologies Co. by 2.9 percent for the top spot, according to market researcher Counterpoint Research.
Xiaomi Corp., another Chinese firm came in third with a 22.6 percent share followed by Apple Inc. with a 9.2 percent.
In terms of online smartphone sales, Samsung was third with a 26.3 percent share, trailing Huawei with 27.8 percent and Xiaomi with 27 percent.
Counter Research attributes the decrease in Samsung's market share for online sales to its decision to depend on offline sales after the restoration of normalcy in retail store operations.
Counterpoint Research noted that Samsung Galaxy A51, Samsung Galaxy A31, and Apple iPhone 11 were the top-sellers on online platforms.
Meanwhile, offline platforms have Samsung Galaxy A51, Redmi Note 8T, and Samsung Galaxy A31 as their best sellers.
Third-quarter sales of smartphones in Russia grew 5 percent on-year, with 34 percent purchased online due to the pandemic.


Nvidia Invests $1 Billion in Naver as South Korea AI Data Center Expansion Gains Momentum
AstraZeneca Q2 Earnings Beat Forecasts as Oncology Growth Supports 2026 Outlook
Serica Energy to Acquire Pharos Energy for £145.7M, Sending PHARP Shares Soaring
Zhongji Innolight Raises $6.8 Billion in Hong Kong IPO as AI Demand Fuels Growth
Standard Chartered Beats Profit Forecasts as First-Half Earnings Rise 9%
Brown-Forman Rejects Sazerac’s $15 Billion Takeover Bid as Family Backs Independence
CXMT IPO Debut in Shanghai Puts $85.5 Billion Chipmaker in Spotlight
Rio Tinto Stock Jumps as Strong Earnings, Higher Dividend and AI Metal Demand Boost Outlook
Zabka Shares Drop 10% as Seven & i Abandons Investment Plans
Meta CEO Zuckerberg Opposes U.S. Ban on Chinese AI Models, Warns Against Overregulation
SK Hynix Q2 Profit Hits Record as AI Memory Chip Demand Fuels Growth
TeamViewer Shares Fall Despite Profit Growth as ARR and Customer Base Decline
CATL Shares Jump as $5.6 Billion Buyback Signals Confidence in Long-Term Growth
Exosens H1 Profit Beats Forecasts as Defense Demand Drives Growth
GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline
Tech Stock Positioning Nears Neutral as Investor Rotation Enters Final Phase, Deutsche Bank Says 



